Alto Neuroscience Overview and Background - Amit Etkin, M.D., Ph.D. - Founder & CEO
Understanding MDD with poor memory - Amit Etkin, M.D., Ph.D. - Founder & CEO
- Clinician Perspective - Dr. Gerard Sanacora
Mechanism of ALTO-100 & Link to Patient Population - Amit Etkin, M.D., Ph.D. - Founder & CEO
ALTO-100 Clinical Development
- Development history - Amit Etkin, M.D., Ph.D. - Founder & CEO
- Phase 2b clinical study overview - Jessica Powell - Chief Development Officer
- Baseline characteristics - Adam Savitz, M.D., Ph.D. - Chief Medical Officer
Commercialization Considerations - Michael Hanley - Chief Operating Officer
- Overview of cognition biomarker data - audience performance
Expert Perspective - Gerard Sanacora, Ph.D. M.D. -- George D. and Esther S. Gross Professor of Psychiatry, Director of Yale Depression Research Program, Yale University
Question & Answer - All